Rocket Lab Stock Reverses After Record Contract as $1B Offering Sparks Selloff

Rocket Lab Corporation (RKLB) stock grabbed headlines this week after securing its single largest contract ever: a $190 million deal for 20 HASTE hypersonic test launches, pushing its total backlog above $2 billion. The news initially sent shares surging on Tuesday, March 17, but a concurrent $1 billion at-the-market equity offering announcement triggered a sharp reversal. As of Thursday morning, RKLB is trading near $71, down roughly 10% from the week’s highs, with fresh analyst coverage from Clear Street adding a bullish $88 price target into the mix.

Key Drivers of the RKLB Stock Move

• Main Catalyst: Rocket Lab announced a record $190M block-buy contract with the Test Resource Management Center for 20 hypersonic test flights via its HASTE launch vehicle, cementing its role as a defense prime and pushing total backlog over $2B.
• Bull Case: A growing defense backlog, 83 successful missions, Clear Street initiating with Buy at $88, Morgan Stanley and Bank of America both carrying Buy ratings with targets at $105 and $120 respectively, and the $1B offering positioned as a strategic war chest for expansion all support optimism.
• Bear Case: The $1B share offering is a meaningful dilution event. Insider selling has been broad and persistent in 2026, including the CFO disposing of over $103M worth of shares in January. The Neutron rocket program continues to face delays, and the stock has pulled back sharply off its highs.

The setup reflects a company navigating a pivotal transition: revenue and backlog are growing, but the combination of dilutive fundraising and insider selling creates real near-term overhead. Investors need to weigh whether the $1B capital raise accelerates Neutron and manufacturing scale-up fast enough to justify the dilution. With the stock now trading well below several analyst price targets, the gap between where it is and where the Street expects it could be either an opportunity or a warning sign that growth execution remains uncertain.

RKLB Smart Money Activity

Insider selling has been consistent and broad throughout early 2026. CFO Adam Spice disposed of $103.1M worth of shares in January, the largest single transaction on record in this period. CEO Peter Beck, COO Frank Klein, General Counsel Arjun Kampani, and Director Merline Saintil have all sold shares in March as well, with the cluster of sales coming right around the earnings event on March 2. While pre-planned selling schedules are possible, the volume and timing across multiple officers is notable. No congressional trades for RKLB were reported in this period.

RKLB Unusual Options

Options flow over March 17 to 19 has been unusually heavy, with a mixed but call-heavy tone. The most notable single flow on March 17 included a bullish sweep of the Apr 17 $80 CALL at $466.6K premium and a bullish sweep of the Jul 17 $90 CALL at $97.8K. On March 18, a massive bullish sweep of the Apr 17 $75 CALL printed at $780.8K, while bearish activity also surfaced, notably a $486.5K sweep of Apr 17 $65 PUTs and multiple large blocks on Oct $55 PUTs. Today (March 19), a notable sweep of the Jun 18 $115 CALLs printed $184.6K bullish. The overall picture is bifurcated: large bullish call sweeps at near-term and mid-term strikes coexist with sizable put protection, reflecting genuine uncertainty around the dilution overhang.

RKLB Analyst Focus

• Top Upgrades / New Coverage: Clear Street initiated with Buy at $88 (March 19). Morgan Stanley upgraded to Buy with a target raised from $67 to $105 (January 16). Bank of America confirmed Buy, raising target from $60 to $120 (January 20).
• Top Downgrades: Keybanc downgraded to Hold (January 15).
• Recent Confirms: Cantor Fitzgerald reiterates Buy at $85. Needham confirms Buy but trimmed target from $110 to $95 post-earnings.
• Median Price Target (active Buy ratings): Approximately $95 to $105, with the highest target at $120 (Bank of America).

RKLB Seasonality

Based on data since November 2020 (5 to 6 samples per month, so treat with caution given the limited history). RKLB has historically struggled in February and March, averaging -9.0% and -5.0% respectively, which aligns with the current pullback. The current period is consistent with the seasonal pattern. The historically stronger months are June (+12.6%), July (+15.4%), November (+24.1%), and September (+11.6%), suggesting the May through July window has historically been a stronger period for the stock. Note: RKLB only went public in late 2020, so the sample size of ~5 per month limits the statistical weight of these observations.

RKLB Relative Performance

RKLB has had a volatile relative performance path vs. its sector peers this year. It started 2026 ranked in approximately the 98th percentile of its sector, then dropped sharply to the low 70s through mid-February, likely tied to post-earnings disappointment and Neutron delay headlines. It has since recovered to the high 80s to low 90s, closing March 18 at the ~89th percentile. The surge on March 17 briefly pushed it back near 95th percentile territory, before the offering news weighed it back down. Despite the dilution shock, RKLB is still outperforming the vast majority of its sector peers on a technical basis.